Wu Q - Search Results

1

The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data.

Zhang B, Wu Q, Xu R, Hu X, Sun Y, Wang Q, Ju F, Ren S, Zhang C, Qi F, Ma Q, Wang Z, Zhou YL. Zhang B, et al. Among authors: wu q. J Cell Biochem. 2019 Sep;120(9):15106-15118. doi: 10.1002/jcb.28773. Epub 2019 Apr 24. J Cell Biochem. 2019. PMID: 31020692

2

The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data.

Zhang B, Wu Q, Wang Z, Xu R, Hu X, Sun Y, Wang Q, Ju F, Ren S, Zhang C, Qin L, Ma Q, Zhou YL. Zhang B, et al. Among authors: wu q. Mol Genet Genomic Med. 2019 May;7(5):e607. doi: 10.1002/mgg3.607. Epub 2019 Feb 21. Mol Genet Genomic Med. 2019. PMID: 30793530 Free PMC article.

3

Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.

Wu Q, Zhang B, Wang Z, Hu X, Sun Y, Xu R, Chen X, Wang Q, Ju F, Ren S, Zhang C, Qi F, Ma Q, Xue Q, Zhou YL. Wu Q, et al. Pathol Res Pract. 2019 May;215(5):1038-1048. doi: 10.1016/j.prp.2019.02.012. Epub 2019 Feb 28. Pathol Res Pract. 2019. PMID: 30975489

4

Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis.

Wu Q, Zhang B, Sun Y, Xu R, Hu X, Ren S, Ma Q, Chen C, Shu J, Qi F, He T, Wang W, Wang Z. Wu Q, et al. Onco Targets Ther. 2019 May 13;12:3545-3563. doi: 10.2147/OTT.S198621. eCollection 2019. Onco Targets Ther. 2019. PMID: 31190860 Free PMC article.

5

Erratum: The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer.

Zhang B, Wu Q. Zhang B, et al. Among authors: wu q. Int J Cancer. 2019 Apr 1;144(7):E2. doi: 10.1002/ijc.31820. Epub 2018 Dec 7. Int J Cancer. 2019. PMID: 30715737 No abstract available.

6

Correlation between patients' age and cancer immunotherapy efficacy.

Wu Q, Wang Q, Tang X, Xu R, Zhang L, Chen X, Xue Q, Wang Z, Shi R, Wang F, Ju F, Zhang B, Zhou YL. Wu Q, et al. Oncoimmunology. 2019 Feb 3;8(4):e1568810. doi: 10.1080/2162402X.2019.1568810. eCollection 2019. Oncoimmunology. 2019. PMID: 30906662 Free PMC article.

7

Effect of region on the Outcome of Patients Receiving PD-1/PD-L1 Inhibitors for Advanced Cancer.

Wang Z, Zhang B, Zhang C, Ren S, Wang W, Wang Y, Jiang T, Wei H, Li Y, Wu Q, Chen J. Wang Z, et al. Among authors: wu q. Int Immunopharmacol. 2019 Sep;74:105709. doi: 10.1016/j.intimp.2019.105709. Epub 2019 Jul 2. Int Immunopharmacol. 2019. PMID: 31276976 Review.

8

m⁶A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer.

Zhang B, Wu Q, Li B, Wang D, Wang L, Zhou YL. Zhang B, et al. Among authors: wu q. Mol Cancer. 2020 Mar 12;19(1):53. doi: 10.1186/s12943-020-01170-0. Mol Cancer. 2020. PMID: 32164750 Free PMC article.

9

Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.

Wu Q, Wang L, Wei H, Li B, Yang J, Wang Z, Xu J, Zhou YL, Zhang B. Wu Q, et al. Int Immunopharmacol. 2020 Jun;83:106477. doi: 10.1016/j.intimp.2020.106477. Epub 2020 Apr 8. Int Immunopharmacol. 2020. PMID: 32278127

10

Pigtail Catheter Drainage Can Be Considered as the Initial Treatment Option for Patients With Pneumothorax: Not Yet Determined.

Wu Q, Zhou YL. Wu Q, et al. Chest. 2018 Oct;154(4):994-995. doi: 10.1016/j.chest.2018.06.036. Chest. 2018. PMID: 30290944 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,478 results

Search Page

Filters